Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03202875
What this trial is testing

Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Sanofi 30
Not applicableStudy completedNCT00665093
What this trial is testing

Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,569
Not applicableStudy completedNCT00789711
What this trial is testing

An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,131
Post-approval studies (Phase 4)Study completedNCT01467401
What this trial is testing

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 292
Post-approval studies (Phase 4)UnknownNCT04620967
What this trial is testing

Fast-Acting Insulin Aspart and Insulin Pump Settings

Who this might be right for
Type 1 Diabetes
Kirsten Nørgaard 40
Large-scale testing (Phase 3)Study completedNCT02906917
What this trial is testing

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 532
Not applicableStudy completedNCT01536652
What this trial is testing

Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 4,994
Large-scale testing (Phase 3)Study completedNCT01272193
What this trial is testing

Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 296
Early research (Phase 1)Study completedNCT03215498
What this trial is testing

A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 58
Not applicableStudy completedNCT05221580
What this trial is testing

China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 887
Early research (Phase 1)Study completedNCT00184613
What this trial is testing

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Delivery Systems
Novo Nordisk A/S 22
Post-approval studies (Phase 4)Ended earlyNCT00509925
What this trial is testing

Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 23
Large-scale testing (Phase 3)Study completedNCT02034513
What this trial is testing

A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 501
Large-scale testing (Phase 3)Ended earlyNCT00322257
What this trial is testing

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 596
Not applicableEnded earlyNCT00428207
What this trial is testing

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

Who this might be right for
Type 1 Diabetes Mellitus
Joslin Diabetes Center 4
Early research (Phase 1)Study completedNCT01520831
What this trial is testing

Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 35
Large-scale testing (Phase 3)Study completedNCT01819129
What this trial is testing

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 881
Not applicableStudy completedNCT01487369
What this trial is testing

Special Survey of Production of Insulin Aspart Specific Antibody

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 204
Not applicableStudy completedNCT05224258
What this trial is testing

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Who this might be right for
Type 1 Diabetes
Medtronic MiniMed, Inc. 240
Large-scale testing (Phase 3)Study completedNCT00598793
What this trial is testing

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 242
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation